Pharyngeal Diseases: Clinical Trials

2,370 trials for Pharyngeal Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

962 completed, 533 unknown, 376 recruiting, 140 not yet recruiting. 823 Not applicable, 586 Phase 2, 267 Phase 3, 198 Phase 1, 68 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable823Completed 378, Unknown 171, Recruiting 108, Not yet recruiting 53, Terminated 39, Withdrawn 37, Active not recruiting 19, Enrolling by invitation 13, Suspended 5
Phase 2586Completed 186, Unknown 154, Recruiting 101, Active not recruiting 44, Terminated 41, Not yet recruiting 38, Withdrawn 18, Suspended 3, Enrolling by invitation 1
Phase 3267Completed 89, Recruiting 58, Unknown 57, Active not recruiting 29, Terminated 16, Not yet recruiting 15, Withdrawn 2, Enrolling by invitation 1
Phase 1198Completed 86, Unknown 33, Recruiting 28, Terminated 18, Active not recruiting 15, Not yet recruiting 11, Withdrawn 7
Phase 468Completed 33, Unknown 16, Recruiting 9, Terminated 4, Not yet recruiting 3, Withdrawn 2, Active not recruiting 1
Early Phase 122Completed 6, Recruiting 5, Unknown 5, Not yet recruiting 3, Terminated 3

Follow Pharyngeal Diseases: new trials by email Literature Review of Pharyngeal Diseases trials Research Report on Pharyngeal Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AI-Enabled Mobile App for Safe Eating in Older Adults With Dysphagia
AI-Enabled Mobile Application plus Standard Care, Standard Dysphagia Education - Deglutition Disorders, Dysphagia
Not applicableNot yet recruitingKAM Chi Shan Anna3322028-01-012026-09-23
Optimizing Dysphagia Treatment Delivery in Acute Care: A Hybrid Efficacy Implementation Trial
Expiratory muscle strength training (EMST), Standard of Care Dysphagia Treatment, Intensive Dysphagia Treatment - Dysphagia, Critical Illness
Not applicableNot yet recruitingVanderbilt University Medical Center1202027-07-012026-10-14
Parent Implemented Oral Nutrition, Eating, and Esophageal Reflexes Reintegration Protocol: RCT
PIONEER Protocol - Deglutition Disorders in Infants, Chronic Tube Feeding in Hospitalized Infants
Not applicableNot yet recruitingNationwide Children's Hospital1302027-07-012026-08-28
Removing the Planning Tumor Volume From Radiation Therapy for the Treatment of Head and Neck Squamous Cell Carcinoma
Chemotherapy, Computed Tomography, Endoscopic Procedure - Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Not applicableNot yet recruitingCity of Hope Medical Center302027-06-222026-11-09
Swallowing Impairments in ICU Survivors and Community-Dwelling Adults
Dysphagia, Healthy Aging
WithdrawnVanderbilt University Medical Center2027-04-012026-06-02
Maximizing Quality of Life After Cancer Through Rehabilitation
TIMELY REHAB - Head and Neck Cancer, Hearing Loss
Not applicableNot yet recruitingVA Office of Research and Development742027-03-012026-06-03
Proactively Intervening On Early Cranial Nerve Injury As A Delayed Sequela Of Oropharyngeal Cancer: A Randomized Feasibility Clinical Trial For Pro-Habilitation (proNERVE RCT)
Prednisone, Ajovy, Manual Therapy - Cranial Nerve Injury, Oropharyngeal Cancer
Phase 1Not yet recruitingM.D. Anderson Cancer Center482027-03-012026-09-21
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Biospecimen Collection, Camonsertib, Computed Tomography - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 1RecruitingNational Cancer Institute (NCI)392027-02-132026-10-29
Aspiration Pneumonia in Adults: Patient Characteristics, Diagnosis, Treatment, and Outcomes
Antibiotic Treatment in Routine Clinical Care - Aspiration Pneumonias
Not yet recruitingRegion Örebro County3002027-01-052026-11-12
Interest of Telemedicine in Primary Care in an Multidisability Population Institutionalized
Experimental procedure: swallowing assessment by telemedicine, Standard procedure: day hospitalization - Deglutition Disorders in Disabled Persons
Not applicableNot yet recruitingUniversity Hospital, Toulouse622027-01-012026-08-28
Exploring the Efficacy of the Effortful Swallow Maneuver for Improving Swallowing in People With PD
Effortful swallow - Dysphagia, Parkinson Disease (PD)
Not applicableNot yet recruitingUniversity of Alberta742027-01-012026-08-19
Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures
Ultrasound for cough, Ultrasound for vocal fold atrophy or vocal fold paresis/paralysis, Ultrasound for dysphagia - Cough, Vocal Cord Atrophy
Not applicableNot yet recruitingWeill Medical College of Cornell University2002027-01-012026-06-16
Deep Brain Stimulation + Therapy for Stroke
Boston Scientific Vercise Deep Brain Stimulation (DBS) System, Rehabilitation Training Protocol - Stroke, Dysarthria
Not applicableNot yet recruitingPirondini, Elvira, PhD152027-01-012026-09-30
Intravenous LIGNOcaine for the POstoperative Sore Throat
Intravenous lignocaine, Normal Saline (0.9% NaCl) - Postoperative Sore Throat, Cough, Hoarseness, Postoperative Complications
Phase 4Not yet recruitingUniversity of Malaya3982027-01-012026-11-13
Effects of Different-Frequency Electroacupuncture on Suprahyoid Muscles in Post-Stroke Dysphagia: Efficacy and Neural Networks
Low Frequency EA, Medium Frequency EA, High Frequency EA - Stroke Sequelae, Deglutition Disorders
Not applicableNot yet recruitingKaili Chen1022026-12-212026-09-24
Early Feeding TL Trial
oral intake - Total Laryngectomy
Phase 2Not yet recruitingUniversity of Florida1202026-12-162026-11-05
EndoFLIP-Guided Initial Management of Esophagogastric Junction Outflow Obstruction
EndoFLIP Panometry, Botulinum Toxin Type A (BOTOX) Injection - Esophagogastric Junction Outflow Obstruction
Not applicableNot yet recruitingHospital Clinic of Barcelona1152026-12-072026-11-10
A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma
Cemiplimab, Fianlimab - Nasopharyngeal Carcinoma, Nasopharyngeal Cancer
Phase 1Not yet recruitingMemorial Sloan Kettering Cancer Center602026-12-012026-11-03
Dynamic Plasma EBV DNA-Guided Risk-Adapted Treatment With Becotatug Vedotin (MRG003) Plus PD-1 Blockade in Locoregionally Advanced Nasopharyngeal Carcinoma
Becotatug Vedotin, Pucotenlimab, Intensity-Modulated Radiotherapy - Nasopharyngeal Cancinoma (NPC), Nasopharyngeal Cancer
Phase 2Not yet recruitingSun Yat-sen University2982026-12-012026-10-27
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Hypofractionated Stereotactic Body Radiotherapy (SBRT), Pembrolizumab, Ficerafusp alfa - Head and Neck Squamous Cell Carcinoma, HPV-Negative Squamous Cell Carcinoma
Phase 1 / Phase 2Not yet recruitingWashington University School of Medicine452026-11-302026-11-03

Showing 20 of 2370. Sign in to see all of them.

Narrower conditions

Deglutition Disorders (841)  ·  Nasopharyngeal Carcinoma (651)  ·  Oropharyngeal Neoplasms (368)  ·  Head and Neck Neoplasms (240)  ·  Pharyngitis (227)  ·  Nasopharyngeal Neoplasms (224)  ·  Mouth Neoplasms (162)  ·  Laryngeal Neoplasms (157)  ·  Hypopharyngeal Neoplasms (147)  ·  Stroke (145)  ·  Squamous Cell Carcinoma of Head and Neck (140)  ·  Tonsillitis (89)  ·  Esophageal Neoplasms (56)  ·  Uterine Cervical Neoplasms (52)  ·  Carcinoma, Non-Small-Cell Lung (49)

Broader conditions

Otorhinolaryngologic Diseases (2361)  ·  Stomatognathic Diseases (1576)  ·  Neoplasms by Site (1279)  ·  Neoplasms (1255)  ·  Otorhinolaryngologic Neoplasms (1211)  ·  Pharyngeal Neoplasms (1179)  ·  Head and Neck Neoplasms (1042)  ·  Digestive System Diseases (938)  ·  Gastrointestinal Diseases (931)  ·  Esophageal Diseases (881)  ·  Neoplasms by Histologic Type (835)  ·  Nasopharyngeal Diseases (832)  ·  Neoplasms, Glandular and Epithelial (826)  ·  Carcinoma (775)

Interventions

Cisplatin (232)  ·  Radiotherapy, Intensity-Modulated (108)  ·  Gemcitabine (96)  ·  Radiotherapy (75)  ·  Docetaxel (61)  ·  Fluorouracil (55)  ·  toripalimab (51)  ·  Capecitabine (44)  ·  Drug Therapy (38)  ·  Carboplatin (35)  ·  pembrolizumab (35)  ·  Magnetic Resonance Spectroscopy (32)  ·  Radiation (32)  ·  Cetuximab (31)  ·  camrelizumab (29)

Sponsors

Sun Yat-sen University (214)  ·  National Cancer Institute (NCI) (49)  ·  Fudan University (36)  ·  M.D. Anderson Cancer Center (36)  ·  National Taiwan University Hospital (28)  ·  Zhejiang Cancer Hospital (24)  ·  Mayo Clinic (22)  ·  University Health Network, Toronto (22)  ·  University of Florida (20)  ·  Fujian Cancer Hospital (18)  ·  Zeng Changhao (18)  ·  Seoul National University Hospital (16)  ·  Hospital de Mataró (15)  ·  National University Hospital, Singapore (15)  ·  University of Wisconsin, Madison (15)

Countries

United States (626)  ·  China (612)  ·  France (114)  ·  Canada (100)  ·  Turkey (Türkiye) (100)  ·  Taiwan (92)  ·  Spain (61)  ·  Germany (56)  ·  South Korea (53)  ·  Italy (50)  ·  Singapore (50)  ·  United Kingdom (49)  ·  Denmark (37)  ·  Egypt (30)  ·  Sweden (30)

Top investigators

Nieto Luis, Master (21)  ·  Jun Ma, M.D. (14)  ·  Ming-Yuan Chen, MD,PhD (11)  ·  Ming-Yuan Chen, MD, PhD (9)  ·  Nieto Luis (8)  ·  Chaosu Hu, MD (7)  ·  Jiade J Lu, MD (6)  ·  Rosemary Martino, PhD (6)  ·  Emily K Plowman, PhD (5)  ·  Fang-Yun Xie, M.D. (5)  ·  Ming-yuan Chen, MD, PhD (5)  ·  Yun-fei Xia, MD (5)

Results publications

PMID 31150573, PMID 27158989, PMID 30207593, PMID 27686945, PMID 28837405, PMID 29584545, PMID 34341578, PMID 17270511, PMID 21441148, PMID 26171894, PMID 30213452, PMID 31178151, PMID 33492986, PMID 35240053, PMID 35997729, PMID 36746459, PMID 38507662, PMID 39970442, PMID 10734019, PMID 15385385, PMID 16137276, PMID 19564532, PMID 20870978, PMID 22154591, PMID 25296661, PMID 25850008, PMID 26787799, PMID 26966356, PMID 27398981, PMID 27567279, PMID 27567280, PMID 27883209, PMID 28677236, PMID 29806864, PMID 30320644, PMID 30620929, PMID 30956054, PMID 31536129, PMID 32017652, PMID 33799960, PMID 34111416, PMID 34174189, PMID 34990291, PMID 35355438, PMID 35639525, PMID 35709465, PMID 36142680, PMID 37207654, PMID 37409613, PMID 37537541

NIH funding

U10CA180868 (8), 2019 (7), P30CA138292 (6), U10CA180820 (6), 2023 (5), 2015 (4), 2018 (4), R01DC011020 (4), 2016 (3), U10CA180821 (3), 2008 (2), 2014 (2), 2017 (2), K23DK127251 (2), K76AG068590 (2)